Breaking News Instant updates and real-time market news.

KDNY

Chinook Therapeutics

$12.76 /

-0.32 (-2.45%)

08:19
01/24/22
01/24
08:19
01/24/22
08:19

Chinook appoints Jones-Burton as SVP of product development, strategy

Chinook Therapeutics announced the appointment of Charlotte Jones-Burton, M.D., M.S. as senior vice president, SVP, of product development and strategy. Dr. Jones-Burton joins Chinook from Otsuka Pharmaceuticals, where she most recently served as vice president of global clinical development and head of nephrology.

  • 10

    Nov

OTHER BREAKING NEWS FROM THE FLY

Downgrade
Frontdoor downgraded to Hold from Buy at Truist » 06:41
05/23/22
05/23
06:41
05/23/22
06:41
FTDR

Frontdoor

$26.45 /

+0.245 (+0.94%)

Truist analyst Youssef…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FTDR Frontdoor
$26.45 /

+0.245 (+0.94%)

FTDR Frontdoor
$26.45 /

+0.245 (+0.94%)

05/06/22 Truist
Frontdoor price target lowered to $32 from $50 at Truist
05/06/22 Raymond James
Frontdoor price target lowered to $31 from $40 at Raymond James
05/06/22 Oppenheimer
Frontdoor price target lowered to $34 from $41 at Oppenheimer
01/06/22 Goldman Sachs
Frontdoor assumed with a Neutral at Goldman Sachs
FTDR Frontdoor
$26.45 /

+0.245 (+0.94%)

Conference/Events
Timken management to meet with Loop Capital » 06:40
05/23/22
05/23
06:40
05/23/22
06:40
TKR

Timken

$57.88 /

-0.735 (-1.25%)

Meetings to be held in CA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TKR Timken
$57.88 /

-0.735 (-1.25%)

TKR Timken
$57.88 /

-0.735 (-1.25%)

05/03/22 KeyBanc
Timken price target lowered to $75 from $84 at KeyBanc
04/13/22 Oppenheimer
Timken initiated with an Outperform at Oppenheimer
02/15/22 Evercore ISI
Timken upgraded to Outperform at Evercore ISI on relative valuation
02/15/22 Evercore ISI
Oshkosh downgraded to In Line at Evercore ISI on relative valuation
TKR Timken
$57.88 /

-0.735 (-1.25%)

Upgrade
TreeHouse upgraded to Buy from Hold at Truist » 06:40
05/23/22
05/23
06:40
05/23/22
06:40
THS

TreeHouse

/

+

Truist analyst Bill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
THS TreeHouse
/

+

THS TreeHouse
/

+

03/22/22 Truist
TreeHouse price target lowered to $35 from $40 at Truist
THS TreeHouse
/

+

THS TreeHouse
/

+

Initiation
Upwork initiated with a Sector Perform at RBC Capital » 06:40
05/23/22
05/23
06:40
05/23/22
06:40
UPWK

Upwork

$18.32 /

+0.24 (+1.33%)

, MSFT

Microsoft

$252.57 /

-0.44 (-0.17%)

RBC Capital analyst Brad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UPWK Upwork
$18.32 /

+0.24 (+1.33%)

MSFT Microsoft
$252.57 /

-0.44 (-0.17%)

UPWK Upwork
$18.32 /

+0.24 (+1.33%)

05/17/22 Piper Sandler
'Interesting time' to be looking at Upwork story, says Piper Sandler
05/16/22 Stifel
Upwork downgraded to Hold from Buy at Stifel
04/28/22 Needham
Upwork price target lowered to $33 from $42 at Needham
04/28/22 Canaccord
Upwork price target lowered to $36 from $40 at Canaccord
MSFT Microsoft
$252.57 /

-0.44 (-0.17%)

05/19/22 RBC Capital
Microsoft investor meetings indicate no change to macro/demand, says RBC Capital
05/13/22 Tigress Financial
Microsoft pullback 'major buying opportunity,' says Tigress Financial
05/06/22 Benchmark
Playstudios could still be target as industry consolidates, says Benchmark
04/29/22 OTR Global
Okta view downgraded to Negative from Mixed at OTR Global
UPWK Upwork
$18.32 /

+0.24 (+1.33%)

MSFT Microsoft
$252.57 /

-0.44 (-0.17%)

MSFT Microsoft
$252.57 /

-0.44 (-0.17%)

UPWK Upwork
$18.32 /

+0.24 (+1.33%)

MSFT Microsoft
$252.57 /

-0.44 (-0.17%)

UPWK Upwork
$18.32 /

+0.24 (+1.33%)

MSFT Microsoft
$252.57 /

-0.44 (-0.17%)

Initiation
Radius Health initiated with a Market Perform at SVB Leerink » 06:40
05/23/22
05/23
06:40
05/23/22
06:40
RDUS

Radius Health

$6.25 /

+0.41 (+7.03%)

, AMGN

Amgen

$247.42 /

+2.48 (+1.01%)

SVB Leerink analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RDUS Radius Health
$6.25 /

+0.41 (+7.03%)

AMGN Amgen
$247.42 /

+2.48 (+1.01%)

RDUS Radius Health
$6.25 /

+0.41 (+7.03%)

12/23/21 Stifel
New Radius' Tymlos label offers slight expansion potential, says Stifel
12/10/21 Morgan Stanley
Radius Health downgraded to Underweight from Equal Weight at Morgan Stanley
12/09/21 Goldman Sachs
Radius Health downgraded to Neutral from Buy at Goldman Sachs
12/09/21 H.C. Wainwright
Radius Health price target lowered to $10 from $23 at H.C. Wainwright
AMGN Amgen
$247.42 /

+2.48 (+1.01%)

06:20 Today SVB Leerink
Amgen initiated with a Market Perform at SVB Leerink
05/10/22 Mizuho
Amgen price target raised to $208 from $202 at Mizuho
05/05/22 Stifel
ASCO sets up as 'downside-biased' for Mirati investors, says Stifel
04/28/22 BMO Capital
Amgen price target lowered to $243 from $263 at BMO Capital
RDUS Radius Health
$6.25 /

+0.41 (+7.03%)

AMGN Amgen
$247.42 /

+2.48 (+1.01%)

AMGN Amgen
$247.42 /

+2.48 (+1.01%)

RDUS Radius Health
$6.25 /

+0.41 (+7.03%)

AMGN Amgen
$247.42 /

+2.48 (+1.01%)

RDUS Radius Health
$6.25 /

+0.41 (+7.03%)

AMGN Amgen
$247.42 /

+2.48 (+1.01%)

Hot Stocks
American Vanguard issues stockholder letter in support of director nominees » 06:38
05/23/22
05/23
06:38
05/23/22
06:38
AVD

American Vanguard

$22.31 /

-0.52 (-2.28%)

American Vanguard sent a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVD American Vanguard
$22.31 /

-0.52 (-2.28%)

Initiation
Pfizer initiated with a Market Perform at SVB Leerink » 06:38
05/23/22
05/23
06:38
05/23/22
06:38
PFE

Pfizer

$52.46 /

+1.805 (+3.56%)

SVB Leerink analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$52.46 /

+1.805 (+3.56%)

PFE Pfizer
$52.46 /

+1.805 (+3.56%)

05/11/22 H.C. Wainwright
Biohaven Pharmaceutical downgraded to Neutral from Buy at H.C. Wainwright
05/11/22 Wedbush
Global Blood Therapeutics added to Best Ideas List at Wedbush
05/05/22 Stifel
Stifel keeps Buy rating on Arvinas, lowers price target to $82
05/04/22 Wells Fargo
Pfizer price target lowered to $55 from $60 at Wells Fargo
PFE Pfizer
$52.46 /

+1.805 (+3.56%)

PFE Pfizer
$52.46 /

+1.805 (+3.56%)

PFE Pfizer
$52.46 /

+1.805 (+3.56%)

PFE Pfizer
$52.46 /

+1.805 (+3.56%)

Hot Stocks
Ocugen: FDA removes clinical hold on Phase 2/3 clinical trial for COVAXIN » 06:37
05/23/22
05/23
06:37
05/23/22
06:37
OCGN

Ocugen

$2.23 /

-0.01 (-0.45%)

Ocugen announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OCGN Ocugen
$2.23 /

-0.01 (-0.45%)

OCGN Ocugen
$2.23 /

-0.01 (-0.45%)

05/08/22 Chardan
Chardan keeps Neutral on Ocugen, lowers price target to $3.50
04/18/22 Roth Capital
Roth views Ocugen getting rights in Mexico as 'great news'
03/29/22 Chardan
Ocugen price target lowered to $4 from $4.50 at Chardan
03/04/22 Roth Capital
Roth says EUA denial takes accelerated Covaxin paths in U.S. off table in 2022
OCGN Ocugen
$2.23 /

-0.01 (-0.45%)

  • 23
    Feb
OCGN Ocugen
$2.23 /

-0.01 (-0.45%)

OCGN Ocugen
$2.23 /

-0.01 (-0.45%)

OCGN Ocugen
$2.23 /

-0.01 (-0.45%)

Recommendations
Nvidia price target lowered to $280 from $350 at UBS » 06:37
05/23/22
05/23
06:37
05/23/22
06:37
NVDA

Nvidia

$167.18 /

-3.95 (-2.31%)

UBS analyst Timothy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVDA Nvidia
$167.18 /

-3.95 (-2.31%)

NVDA Nvidia
$167.18 /

-3.95 (-2.31%)

05/20/22 Wells Fargo
Nvidia price target lowered to $250 from $370 at Wells Fargo
05/20/22 Daiwa
Daiwa sees six month 'danger zone' for semiconductor stocks
05/19/22 Wedbush
Nvidia price target lowered to $190 from $300 at Wedbush
05/19/22 Oppenheimer
Nvidia price target lowered to $300 from $350 at Oppenheimer
NVDA Nvidia
$167.18 /

-3.95 (-2.31%)

NVDA Nvidia
$167.18 /

-3.95 (-2.31%)

NVDA Nvidia
$167.18 /

-3.95 (-2.31%)

NVDA Nvidia
$167.18 /

-3.95 (-2.31%)

Initiation
Eli Lilly initiated with an Outperform at SVB Leerink » 06:36
05/23/22
05/23
06:36
05/23/22
06:36
LLY

Eli Lilly

$298.98 /

+12.43 (+4.34%)

SVB Leerink analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$298.98 /

+12.43 (+4.34%)

LLY Eli Lilly
$298.98 /

+12.43 (+4.34%)

05/02/22 Wells Fargo
AbbVie price target raised to $200 from $165 at Wells Fargo
05/02/22 Mizuho
Eli Lilly price target raised to $356 from $315 at Mizuho
04/29/22 Morgan Stanley
Eli Lilly price target raised to $369 from $364 at Morgan Stanley
04/29/22 Wells Fargo
Eli Lilly price target raised to $305 from $280 at Wells Fargo
LLY Eli Lilly
$298.98 /

+12.43 (+4.34%)

LLY Eli Lilly
$298.98 /

+12.43 (+4.34%)

LLY Eli Lilly
$298.98 /

+12.43 (+4.34%)

LLY Eli Lilly
$298.98 /

+12.43 (+4.34%)

Downgrade
Sumitomo Pharma downgraded to Neutral from Buy at Citi » 06:36
05/23/22
05/23
06:36
05/23/22
06:36
DNPUF

Sumitomo Pharma

$9.69 /

+ (+0.00%)

Citi analyst Hidemaru…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DNPUF Sumitomo Pharma
$9.69 /

+ (+0.00%)

08/16/21 Jefferies
Sumitomo Dainippon upgraded to Buy from Hold at Jefferies
06/14/21 Jefferies
Sumitomo Dainippon downgraded to Hold from Buy at Jefferies
Periodicals
Musk's planned takeover of Twitter creates 'chaos tax,' WSJ reports » 06:34
05/23/22
05/23
06:34
05/23/22
06:34
TWTR

Twitter

$38.28 /

+1 (+2.68%)

Within 24-hours,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$38.28 /

+1 (+2.68%)

TWTR Twitter
$38.28 /

+1 (+2.68%)

05/17/22 Wedbush
Tesla shares likely to be under pressure again Tuesday, says Wedbush
05/16/22 Wedbush
Bot issue likely excuse for lower Twitter price or Musk walks away, says Wedbush
05/16/22 Citi
Citi does not expect Twitter deal changes from spam review
05/13/22 Truist
Twitter, Musk deal could get 'messy' if he tries to walk away, says Truist
TWTR Twitter
$38.28 /

+1 (+2.68%)

TWTR Twitter
$38.28 /

+1 (+2.68%)

TWTR Twitter
$38.28 /

+1 (+2.68%)

TWTR Twitter
$38.28 /

+1 (+2.68%)

Periodicals
Electronic Arts reportedly looking to sell or merge, Kotaku reports » 06:34
05/23/22
05/23
06:34
05/23/22
06:34
EA

Electronic Arts

$130.77 /

+0.725 (+0.56%)

, CMCSA

Comcast

$41.99 /

-0.04 (-0.10%)

, DIS

Disney

$102.38 /

-0.81 (-0.78%)

, AAPL

Apple

$137.58 /

+0.26 (+0.19%)

, MSFT

Microsoft

$252.57 /

-0.44 (-0.17%)

, ATVI

Activision Blizzard

$77.40 /

-0.345 (-0.44%)

EA (EA) recently pursued…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EA Electronic Arts
$130.77 /

+0.725 (+0.56%)

CMCSA Comcast
$41.99 /

-0.04 (-0.10%)

DIS Disney
$102.38 /

-0.81 (-0.78%)

AAPL Apple
$137.58 /

+0.26 (+0.19%)

MSFT Microsoft
$252.57 /

-0.44 (-0.17%)

ATVI Activision Blizzard
$77.40 /

-0.345 (-0.44%)

EA Electronic Arts
$130.77 /

+0.725 (+0.56%)

05/17/22 Morgan Stanley
Take-Two price target lowered to $195 from $215 at Morgan Stanley
05/11/22 Wells Fargo
Electronic Arts price target lowered to $145 from $155 at Wells Fargo
05/11/22 Wedbush
Electronic Arts price target lowered to $164 from $180 at Wedbush
05/11/22 Cowen
Electronic Arts price target lowered to $158 from $180 at Cowen
CMCSA Comcast
$41.99 /

-0.04 (-0.10%)

05/06/22 Truist
Cable One price target lowered to $1,400 from $2,000 at Truist
04/29/22 Morgan Stanley
Comcast price target lowered to $55 from $60 at Morgan Stanley
04/29/22 Needham
Accolade price target lowered to $12 from $33 at Needham
04/29/22 Deutsche Bank
Comcast price target lowered to $60 from $62 at Deutsche Bank
DIS Disney
$102.38 /

-0.81 (-0.78%)

05:08 Today KGI Securities
Disney initiated with an Outperform at KGI Securities
05/16/22 Stifel
Trade Desk upgraded to Buy from Hold at Stifel
05/13/22 Barclays
Disney price target lowered to $130 from $168 at Barclays
05/12/22 RBC Capital
Disney price target lowered to $176 from $210 at RBC Capital
AAPL Apple
$137.58 /

+0.26 (+0.19%)

05/20/22 Wedbush
Apple a compelling name to own, ride out market storm, says Wedbush
05/19/22 BofA
BofA raises iPhone estimates, trims Apple price target to $200
05/11/22 JMP Securities
Jamf Holding price target lowered to $39 from $59 at JMP Securities
05/04/22 Benchmark
Cirrus Logic price target lowered to $95 from $100 at Benchmark
MSFT Microsoft
$252.57 /

-0.44 (-0.17%)

05/19/22 RBC Capital
Microsoft investor meetings indicate no change to macro/demand, says RBC Capital
05/13/22 Tigress Financial
Microsoft pullback 'major buying opportunity,' says Tigress Financial
05/06/22 Benchmark
Playstudios could still be target as industry consolidates, says Benchmark
04/29/22 OTR Global
Okta view downgraded to Negative from Mixed at OTR Global
ATVI Activision Blizzard
$77.40 /

-0.345 (-0.44%)

05/06/22 Benchmark
Playstudios could still be target as industry consolidates, says Benchmark
04/25/22 Benchmark
Activision results for Blizzard 'somewhat shocking,' says Benchmark
04/19/22 Goldman Sachs
Activision Blizzard assumed with Not Rated at Goldman Sachs
02/28/22 Benchmark
Playstudios could be target as game industry consolidates, says Benchmark
EA Electronic Arts
$130.77 /

+0.725 (+0.56%)

CMCSA Comcast
$41.99 /

-0.04 (-0.10%)

DIS Disney
$102.38 /

-0.81 (-0.78%)

AAPL Apple
$137.58 /

+0.26 (+0.19%)

MSFT Microsoft
$252.57 /

-0.44 (-0.17%)

ATVI Activision Blizzard
$77.40 /

-0.345 (-0.44%)

EA Electronic Arts
$130.77 /

+0.725 (+0.56%)

CMCSA Comcast
$41.99 /

-0.04 (-0.10%)

DIS Disney
$102.38 /

-0.81 (-0.78%)

AAPL Apple
$137.58 /

+0.26 (+0.19%)

MSFT Microsoft
$252.57 /

-0.44 (-0.17%)

ATVI Activision Blizzard
$77.40 /

-0.345 (-0.44%)

EA Electronic Arts
$130.77 /

+0.725 (+0.56%)

CMCSA Comcast
$41.99 /

-0.04 (-0.10%)

DIS Disney
$102.38 /

-0.81 (-0.78%)

AAPL Apple
$137.58 /

+0.26 (+0.19%)

MSFT Microsoft
$252.57 /

-0.44 (-0.17%)

ATVI Activision Blizzard
$77.40 /

-0.345 (-0.44%)

EA Electronic Arts
$130.77 /

+0.725 (+0.56%)

CMCSA Comcast
$41.99 /

-0.04 (-0.10%)

DIS Disney
$102.38 /

-0.81 (-0.78%)

AAPL Apple
$137.58 /

+0.26 (+0.19%)

MSFT Microsoft
$252.57 /

-0.44 (-0.17%)

ATVI Activision Blizzard
$77.40 /

-0.345 (-0.44%)

Conference/Events
Syros Pharmaceuticals management to meet virtually with Oppenheimer » 06:34
05/23/22
05/23
06:34
05/23/22
06:34
SYRS

Syros Pharmaceuticals

/

+

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SYRS Syros Pharmaceuticals
/

+

SYRS Syros Pharmaceuticals
/

+

05/17/22 H.C. Wainwright
Syros Pharmaceuticals price target lowered to $10 from $15 at H.C. Wainwright
05/16/22 Alliance Global Partners
Syros Pharmaceuticals price target lowered to $10 at Alliance Global Partners
03/16/22 Roth Capital
Roth 'struggles to understand' why Syros trades at $1.15 with 3 readouts ahead
01/10/22 Piper Sandler
Syros Pharmaceuticals price target lowered to $10 from $18 at Piper Sandler
SYRS Syros Pharmaceuticals
/

+

Initiation
Halozyme initiated with an Outperform at SVB Leerink » 06:34
05/23/22
05/23
06:34
05/23/22
06:34
HALO

Halozyme

$44.34 /

+0.47 (+1.07%)

, ATRS

Antares Pharma

$5.59 /

-0.005 (-0.09%)

SVB Leerink analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HALO Halozyme
$44.34 /

+0.47 (+1.07%)

ATRS Antares Pharma
$5.59 /

-0.005 (-0.09%)

HALO Halozyme
$44.34 /

+0.47 (+1.07%)

04/14/22 Truist
Antares Pharma downgraded to Hold from Buy at Truist
04/14/22 Raymond James
Antares Pharma downgraded to Market Perform from Strong Buy at Raymond James
04/13/22 Piper Sandler
Piper says Antares' auto-injector platform 'clearly complementary' for Halozyme
03/24/22 Benchmark
Halozyme 'off to a good start' to 2022 with Chugai deal, says Benchmark
ATRS Antares Pharma
$5.59 /

-0.005 (-0.09%)

04/14/22 Truist
Antares Pharma downgraded to Hold from Buy at Truist
04/14/22 Ladenburg
Antares Pharma downgraded to Neutral from Buy at Ladenburg
04/14/22 Raymond James
Antares Pharma downgraded to Market Perform from Strong Buy at Raymond James
04/14/22 Piper Sandler
Antares Pharma downgraded to Neutral from Overweight at Piper Sandler
HALO Halozyme
$44.34 /

+0.47 (+1.07%)

ATRS Antares Pharma
$5.59 /

-0.005 (-0.09%)

HALO Halozyme
$44.34 /

+0.47 (+1.07%)

ATRS Antares Pharma
$5.59 /

-0.005 (-0.09%)

Downgrade
Realty Income downgraded to Peer Perform from Outperform at Wolfe Research » 06:33
05/23/22
05/23
06:33
05/23/22
06:33
O

Realty Income

$68.00 /

+0.84 (+1.25%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
O Realty Income
$68.00 /

+0.84 (+1.25%)

O Realty Income
$68.00 /

+0.84 (+1.25%)

03/15/22 Wolfe Research
Realty Income upgraded to Outperform from Peer Perform at Wolfe Research
01/20/22 Mizuho
Realty Income price target lowered to $76 from $82 at Mizuho
12/15/21 Scotiabank
Realty Income downgraded to Sector Perform from Outperform at Scotiabank
12/15/21 Scotiabank
Realty Income downgraded to Sector Perform from Outperform at Scotiabank
O Realty Income
$68.00 /

+0.84 (+1.25%)

  • 01
    Jul
O Realty Income
$68.00 /

+0.84 (+1.25%)

Downgrade
JBG Smith downgraded to Peer Perform from Outperform at Wolfe Research » 06:33
05/23/22
05/23
06:33
05/23/22
06:33
JBGS

JBG Smith Properties

$24.97 /

+0.045 (+0.18%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JBGS JBG Smith Properties
$24.97 /

+0.045 (+0.18%)

JBGS JBG Smith Properties
$24.97 /

+0.045 (+0.18%)

03/03/22 Evercore ISI
Evercore ISI shakes up Office REIT ratings with one upgrade, two downgrades
07/12/21 BMO Capital
JBG Smith Properties initiated with an Outperform at BMO Capital
Hot Stocks
ImmunoGen's BLA for mirvetuximab soravtansine in ovarian cancer accepted by FDA » 06:32
05/23/22
05/23
06:32
05/23/22
06:32
IMGN

ImmunoGen

$3.58 /

+0.055 (+1.56%)

ImmunoGen announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMGN ImmunoGen
$3.58 /

+0.055 (+1.56%)

IMGN ImmunoGen
$3.58 /

+0.055 (+1.56%)

03/21/22 RBC Capital
ImmunoGen downgraded to Sector Perform from Outperform at RBC Capital
02/10/22 BMO Capital
ImmunoGen initiated with an Outperform at BMO Capital
01/03/22 Guggenheim
ImmunoGen, Merus named 'Best Ideas' in oncology-focused biotech at Guggenheim
12/01/21 Jefferies
ImmunoGen upgraded to Buy at Jefferies after 'best-case data' in PROC
IMGN ImmunoGen
$3.58 /

+0.055 (+1.56%)

  • 02
    Dec
IMGN ImmunoGen
$3.58 /

+0.055 (+1.56%)

Initiation
Johnson & Johnson assumed with an Outperform at SVB Leerink » 06:31
05/23/22
05/23
06:31
05/23/22
06:31
JNJ

Johnson & Johnson

$175.81 /

+2.97 (+1.72%)

SVB Leerink analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$175.81 /

+2.97 (+1.72%)

JNJ Johnson & Johnson
$175.81 /

+2.97 (+1.72%)

05/17/22 BofA
Teva upgraded to Neutral at BofA on potential opioid deal upside
05/17/22 Citi
Johnson & Johnson price target lowered to $205 from $210 at Citi
04/29/22 Chardan
Emergent BioSolutions price target lowered to $65 from $75 at Chardan
04/20/22 Credit Suisse
Johnson & Johnson price target raised to $205 from $200 at Credit Suisse
JNJ Johnson & Johnson
$175.81 /

+2.97 (+1.72%)

JNJ Johnson & Johnson
$175.81 /

+2.97 (+1.72%)

JNJ Johnson & Johnson
$175.81 /

+2.97 (+1.72%)

JNJ Johnson & Johnson
$175.81 /

+2.97 (+1.72%)

Hot Stocks
Walmart, Symbotic expand partnership » 06:31
05/23/22
05/23
06:31
05/23/22
06:31
WMT

Walmart

$119.05 /

-0.04 (-0.03%)

Symbotic, an A.I.-powered…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WMT Walmart
$119.05 /

-0.04 (-0.03%)

WMT Walmart
$119.05 /

-0.04 (-0.03%)

05/19/22 MKM Partners
Target price target lowered to $180 from $253 at MKM Partners
05/19/22 Truist
Best Buy price target lowered to $83 from $117 at Truist
05/19/22 Stifel
Costco price target lowered to $515 from $565 at Stifel
05/18/22 BMO Capital
Walmart price target lowered to $165 from $170 at BMO Capital
WMT Walmart
$119.05 /

-0.04 (-0.03%)

WMT Walmart
$119.05 /

-0.04 (-0.03%)

WMT Walmart
$119.05 /

-0.04 (-0.03%)

WMT Walmart
$119.05 /

-0.04 (-0.03%)

Recommendations
Baird a buyer into Petco Q1 results as shares offer good value » 06:31
05/23/22
05/23
06:31
05/23/22
06:31
WOOF

Petco

$15.11 /

-1.655 (-9.87%)

Baird analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WOOF Petco
$15.11 /

-1.655 (-9.87%)

WOOF Petco
$15.11 /

-1.655 (-9.87%)

05/20/22 Needham
Petco seen as 'safe place to hide' on replenishment demand, says Needham
05/20/22 Jefferies
Pet specialty retail selloff overdone, says Jefferies
05/16/22 Morgan Stanley
Petco initiated with an Equal Weight at Morgan Stanley
05/13/22 Citi
Petco price target lowered to $26 from $28 at Citi
WOOF Petco
$15.11 /

-1.655 (-9.87%)

  • 27
    May
WOOF Petco
$15.11 /

-1.655 (-9.87%)

WOOF Petco
$15.11 /

-1.655 (-9.87%)

Recommendations
Mirum Pharmaceuticals price target raised to $69 from $64 at H.C. Wainwright » 06:30
05/23/22
05/23
06:30
05/23/22
06:30
MIRM

Mirum Pharmaceuticals

$25.67 /

+1.46 (+6.03%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MIRM Mirum Pharmaceuticals
$25.67 /

+1.46 (+6.03%)

03/11/22 Raymond James
Mirum Pharmaceuticals price target raised to $74 from $70 at Raymond James
10/11/21 Piper Sandler
Mirum Pharmaceuticals remains undervalued despite catalysts, says Piper Sandler
09/30/21 H.C. Wainwright
Mirum Pharmaceuticals price target raised to $64 from $51 at H.C. Wainwright
09/30/21 Raymond James
Mirum Pharmaceuticals price target raised to $69 from $51 at Raymond James
MIRM Mirum Pharmaceuticals
$25.67 /

+1.46 (+6.03%)

Initiation
Gilead initiated with a Market Perform at SVB Leerink » 06:29
05/23/22
05/23
06:29
05/23/22
06:29
GILD

Gilead

$63.83 /

+0.55 (+0.87%)

SVB Leerink analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$63.83 /

+0.55 (+0.87%)

GILD Gilead
$63.83 /

+0.55 (+0.87%)

05/17/22 BMO Capital
Scholar Rock price target lowered to $55 from $74 at BMO Capital
05/16/22 Piper Sandler
Gilead price target lowered to $69 from $73 at Piper Sandler
04/29/22 Piper Sandler
Gilead price target raised to $73 from $72 at Piper Sandler
04/12/22 Piper Sandler
Gilead price target raised to $72 from $71 at Piper Sandler
GILD Gilead
$63.83 /

+0.55 (+0.87%)

GILD Gilead
$63.83 /

+0.55 (+0.87%)

GILD Gilead
$63.83 /

+0.55 (+0.87%)

GILD Gilead
$63.83 /

+0.55 (+0.87%)

Upgrade
Saia upgraded to Buy from Neutral at UBS » 06:29
05/23/22
05/23
06:29
05/23/22
06:29
SAIA

Saia

/

+

UBS analyst Thomas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAIA Saia
/

+

SAIA Saia
/

+

05/19/22 Citi
Saia price target lowered to $190 from $230 at Citi
05/03/22 Wells Fargo
Saia price target raised to $290 from $273 at Wells Fargo
04/20/22 Raymond James
Saia price target lowered to $275 from $350 at Raymond James
04/08/22 BofA
Saia downgraded to Neutral from Buy at BofA
SAIA Saia
/

+

SAIA Saia
/

+

Recommendations
Boxed price target lowered to $12 from $13 at Citi » 06:28
05/23/22
05/23
06:28
05/23/22
06:28
BOXD

Boxed

$9.31 /

-0.56 (-5.67%)

Citi analyst Ronald Josey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BOXD Boxed
$9.31 /

-0.56 (-5.67%)

BOXD Boxed
$9.31 /

-0.56 (-5.67%)

04/19/22 Citi
Boxed initiated with a Buy at Citi
01/04/22 BTIG
Boxed initiated with a Neutral at BTIG
01/04/22 BTIG
Boxed initiated with a Neutral at BTIG
11/03/21 DA Davidson
Seven Oaks Acquisition initiated with a Buy at DA Davidson
BOXD Boxed
$9.31 /

-0.56 (-5.67%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.